A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) (SKYSCRAPER-03)
Study Number: GO41854
The purpose of this study is to evaluate the efficacy and safety of atezolizumab in combination with tiragolumab compared with durvalumab in participants with locally advanced, unresectable Stage III non-small cell lung cancer (NSCLC) who have received at least two cycles of concurrent platinum-based chemoradiotherapy (CRT) and have not had radiographic disease progression.
Open at Bloomington, Galesburg, Pekin, Peoria, and Peru
- Navigator Ashton, 309-243-3611 firstname.lastname@example.org
- Jessica, 309-243-3615, email@example.com
- Amanda , 309-243-3663, firstname.lastname@example.org